Fabino Enterprises adopts FY26 financials at 15th AGM
- Fabino Enterprises held its 15th AGM on September 29, 2026
- Members adopted standalone and consolidated FY26 financial statements
- Auditor reports for FY26 contained no qualifications or adverse comments
- Special resolution approved for disposal of business via subsidiary shares
*this image is generated using AI for illustrative purposes only.
Fabino Enterprises Ltd held its 15th Annual General Meeting on September 29, 2026, through Video Conferencing. The meeting focused on adopting the standalone and consolidated financial statements for the year ended March 31, 2026.
The company, formerly known as Fabino Life Sciences Limited, reported that the Statutory Auditors and Secretarial Auditor issued clean reports for FY26, with no qualifications or adverse observations affecting the company's functioning. Eight members and six directors attended the virtual meeting, which commenced at 12:30 pm and concluded at 12:56 pm.
Key resolutions passed
Members approved several ordinary and special resolutions during the session. The agenda included the adoption of annual reports, director appointments, auditor re-appointment, and a significant corporate action regarding subsidiary shares.
| Agenda Item | Resolution Type | Status |
|---|---|---|
| Adopt Standalone Financial Statements FY26 | Ordinary | Approved |
| Adopt Consolidated Financial Statements FY26 | Ordinary | Approved |
| Re-appoint Mr. Arihant Jain (retiring by rotation) | Ordinary | Approved |
| Re-appoint M/s D G M S & Co. as Statutory Auditors | Ordinary | Approved |
| Re-appoint Mrs. Tesu Alakh as Independent Director | Special | Approved |
| Regularize Mrs. Deepali Singla as Independent Director | Special | Approved |
| Approve sale/disposal of business via subsidiary shares | Special | Approved |
Corporate governance updates
The board recommended the re-appointment of M/s D G M S & Co., Chartered Accountants, as the Statutory Auditors. Additionally, the meeting addressed board composition changes, including the regularization of Mrs. Deepali Singla as a Non-executive Independent Director and the re-appointment of Mrs. Tesu Alakh to the same role.
Mr. Arihant Jain, who retired by rotation, was re-appointed as a director following his eligibility to offer himself for the position. The company noted that remote e-voting facilities were provided by National Securities Depository Limited (NSDL) from September 25, 2026, to September 28, 2026.
Historical Stock Returns for Fabino Enterprises
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | -49.67% |
What specific strategic objectives will Fabino Enterprises pursue with the capital generated from the approved sale or disposal of subsidiary shares?
How might the regularization of Mrs. Deepali Singla as an Independent Director influence the company's governance standards and investor confidence in the coming fiscal year?
Given the company's rebranding from Fabino Life Sciences, what new industry verticals or operational pivots are expected to drive future revenue growth?
19
Access Market Heat-map & Insights 
Create, Save & Share your Screener 
Use 200+ Screening Filters 
